HERA-CD27

Welcome to the Brand page for “HERA-CD27”, which is offered here for Hera-cd twenty seven; hera-cd two seven;scientific services, scientific and pharmaceutical research in the field of oncology and immunology relating to fusion proteins with tumor necrosis factor superfamily (tnf-sf) moiety; scientific and technological services, protein design and protein engineering in the field of oncology and immunology relating to fusion proteins with tumor necrosis factor superfamily (tnf-sf) moiety; scientific consulting services in the field of protein design and protein engineering regarding fusion proteins with tumor necrosis factor superfamily (tnf-sf) moiety and providing scientific information in the field of protein design and protein engineering regarding fusion proteins with tumor necrosis factor superfamily (tnf-sf) moiety;.

Its status is currently believed to be active. Its class is unavailable. “HERA-CD27” is believed to be currently owned by “Apogenix AG”.